Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus

Published:2015-02-15 Issue:4 Volume:17 Page:426-429
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Davies M. J.¹,Trujillo A.¹,Vijapurkar U.²,Damaraju C. V.²,Meininger G.²

Affiliation:

1. Janssen Scientific Affairs LLC Raritan NJ USA

2. Janssen Research and Development LLC Raritan NJ USA

Funder

Janssen Scientific Affairs, LLC

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12439

Reference14 articles.

1. Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise

2. SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects

3. Safety and Tolerability of Canagliflozin in Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Phase 3 Study Results

4. Hyperuricemia Is Independently Associated with Coronary Heart Disease and Renal Dysfunction in Patients with Type 2 Diabetes Mellitus

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Challenges and Emerging Therapies in the Treatment of Gout;Current Rheumatology Reviews;2024-07-22

2. SGLT2 Inhibitors and Uric Acid Homeostasis;Gout, Urate, and Crystal Deposition Disease;2024-05-31

3. Broader Perspective on Atherosclerosis—Selected Risk Factors, Biomarkers, and Therapeutic Approach;International Journal of Molecular Sciences;2024-05-10

4. How Did the GLP-1RA and SGLT-2i Affect Serum Uric Acid in Diabetic Patients?;Advances in Clinical Medicine;2024

5. Potential Underlying Mechanisms Explaining the Cardiorenal Benefits of Sodium–Glucose Cotransporter 2 Inhibitors;Advances in Therapy;2023-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3